(1)連結純損益計算書

(単位:百万円)

 

 

前連結会計年度

(自 2023年4月1日

至 2024年3月31日)

 

当連結会計年度

(自 2024年4月1日

至 2025年3月31日)

売上収益

 

1,603,672

 

1,912,323

売上原価

 

292,485

 

349,206

売上総利益

 

1,311,187

 

1,563,117

 

 

 

 

 

販売費及び一般管理費

 

740,110

 

843,032

研究開発費

 

294,187

 

327,651

無形資産償却費

 

98,820

 

136,762

無形資産譲渡益

 

9,735

 

1,049

持分法による投資損益

 

3,165

 

259

その他の収益

 

8,691

 

20,344

その他の費用

 

167,814

 

235,768

営業利益

 

25,518

 

41,039

 

 

 

 

 

金融収益

 

11,455

 

7,874

金融費用

 

12,005

 

17,677

税引前利益

 

24,969

 

31,237

法人所得税費用

 

7,924

 

19,510

当期利益

 

17,045

 

50,747

 

 

 

 

 

 

 

 

 

 

当期利益の帰属

 

 

 

 

親会社の所有者

 

17,045

 

50,747

 

 

 

 

 

 

 

 

 

 

1株当たり当期利益

 

 

 

 

基本的1株当たり当期利益(円)

 

9.51

 

28.35

希薄化後1株当たり当期利益(円)

 

9.47

 

28.24

 

E00920 45030 アステラス製薬株式会社 Astellas Pharma Inc. 通期第3号参考様式 [IFRS](連結) IFRS true cte cte 2024-04-01 2025-03-31 FY 2025-03-31 2023-04-01 2024-03-31 2024-03-31 1 false false false 45030 2025-04-25 45030 2024-04-01 2025-03-31 45030 2024-04-01 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-04-01 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45030 2024-04-01 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-04-01 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-04-01 2025-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-04-01 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-04-01 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-04-01 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-04-01 2025-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-04-01 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2024-04-01 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 45030 2024-04-01 2025-03-31 tse-acediffr-45030:HedgingCostIFRSMember 45030 2025-03-31 45030 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45030 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2025-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2025-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 45030 2025-03-31 tse-acediffr-45030:HedgingCostIFRSMember 45030 2023-04-01 2024-03-31 45030 2023-04-01 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2023-04-01 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45030 2023-04-01 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2023-04-01 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2023-04-01 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2023-04-01 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2023-04-01 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2023-04-01 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2023-04-01 2024-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2023-04-01 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2023-04-01 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 45030 2023-04-01 2024-03-31 tse-acediffr-45030:HedgingCostIFRSMember 45030 2024-03-31 45030 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45030 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 45030 2024-03-31 tse-acediffr-45030:HedgingCostIFRSMember 45030 2023-03-31 45030 2023-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2023-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45030 2023-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2023-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2023-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2023-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2023-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2023-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2023-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2023-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2023-03-31 jpigp_cor:TreasurySharesIFRSMember 45030 2023-03-31 tse-acediffr-45030:HedgingCostIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure